Applied DNA Sciences Inc (NASDAQ:APDN), through its subsidiary Applied DNA Clinical Labs (ADCL), has expanded its clinical testing services for mpox (formerly known as monkeypox). Shares rose some 37% ...
Applied DNA Sciences (NASDAQ:APDN) on Monday announced a strategic restructuring and realignment of resources to focus exclusively on its synthetic DNA manufacturing business, LineaRx. As part of ...
STONY BROOK, NY / ACCESSWIRE / April 22, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, today announced that it will effect a ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Applied DNA Sciences ( (APDN)) has ...
Applied DNA Sciences (APDN) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $1.80 per share a year ago. These figures ...
Good day, and welcome to the Applied DNA Sciences First Quarter Fiscal 2025 Financial Results. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference ...
STONY BROOK, NY / ACCESS Newswire / March 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that it will ...
Applied DNA Sciences and BLC Leather Technology Centre are working together to improve leather supply chain transparency. The DNA-based supply chain technology provider signed an agreement with BLC to ...
Applied DNA Sciences Inc (NASDAQ:APDN) shares are trading higher by 6.0% to $1.76 during Tuesday’s session after the company announced it positioned its TR8 PGx testing as pre-emptive testing for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results